🏛️ Verified NIH Record • Updated 2024-11-25
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA) (NCT04349514)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Monash University
🩺 Plain-English Summary (8th-Grade Level)
This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA). There will be three assessment periods (baseline, 12 and 24 months). The study will include approximately 200 individuals with FA and 100 matched controls recruited across the six international academic sites. Other assessments will include secondary clinical and cognitive markers, as well as exploratory blood markers.
Who can join: Review the eligibility criteria below.
Location: University of Florida — Gainesville, Florida
Age range: 5 Years
🧪 Interventions in This Study
- Natural history (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- University of Florida — Gainesville, Florida
- Center for Magnetic Resonance Research, University of Minnesota — Minneapolis, Minnesota
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
- Monash Biomedical Imaging, Monash University — Clayton, Victoria
- Lab of Neuroimaging and Dept of Neurology, University of Campinas (UNICAMP) — São Paulo, São Paulo
- McGill University — Montreal, Quebec
- Department of Neurology, RWTH Aachen University — Aachen,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Friedreich Ataxia
- A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old — Philadelphia, Pennsylvania
- FA Clinical Outcome Measures — Los Angeles, California
- A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia — Los Angeles, California
- Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia — Los Angeles, California
- Clinical Course Of Disease In Participants With FA-CM — La Jolla, California
Explore by condition: All Friedreich Ataxia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.